Home -> Law Blog Directory -> Litigation Blogs -> How Appealing

Litigation

: How Appealing

"Drug Makers Near Old Goal: A Legal Shield."

"Drug Makers Near Old Goal: A Legal Shield." The New York Times today contains an article that begins, "For years, Johnson & Johnson obscured evidence that its popular Ortho Evra birth control patch delivered much more estrogen than standard birth control pills, potentially increasing the risk of blood clots and strokes, according to internal company documents. But because the Food and Drug Administration approved the patch, the company is arguing in court that it cannot be sued by women who claim that they were injured by the product -- even though its old label inaccurately described the amount of estrogen it released. This legal argument is called pre-emption. After decades of being dismissed by courts, the tactic now appears to be on the verge of success, lawyers for plaintiffs and drug companies say."

Full post as published by How Appealing on April 06, 2008 (boomark / email).